Paper Details

  1. Home
  2. Paper Details

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.

Author: BiedermanJ, FaraoneS V, HardingM, HatchM, JonesJ, PrinceJ, SeidmanL, SpencerT, WilensT

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

Tomoxetine is effective and well-tolerated in treating adult attention deficit hyperactivity disorder (ADHD). Further studies are needed to evaluate long-term efficacy.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: The authors assessed the experimental noradrenergic compound tomoxetine as an alternative treatment for adult attention deficit hyperactivity disorder (ADHD). METHOD: They conducted a double-blind, placebo-controlled, crossover study of tomoxetine in 22 adults with well-characterized ADH...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1176/ajp.155.5.693

データ提供：米国国立医学図書館（NLM）

Treating ADHD: A New Hope for Adults

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that can significantly impact an individual's life. This research investigates the effectiveness of tomoxetine, a novel noradrenergic compound, as a treatment for adult ADHD. The study employed a double-blind, placebo-controlled, crossover design, allowing for a rigorous assessment of tomoxetine's efficacy. The researchers found that tomoxetine was well-tolerated and showed significant improvements in ADHD symptoms, particularly in terms of inhibitory capacity. These promising results suggest that tomoxetine could be a valuable alternative treatment option for adults with ADHD.

Tomoxetine: A Potential Game Changer for ADHD

The findings of this study are encouraging, suggesting that tomoxetine could be a valuable addition to the treatment options available for adults with ADHD. Its effectiveness in improving ADHD symptoms and its favorable tolerability profile warrant further investigation and potential clinical application. Additional research is needed to determine the long-term efficacy and safety of tomoxetine in larger and more diverse populations.

Navigating the ADHD Landscape

Imagine ADHD as a challenging desert landscape, filled with shifting sands and unpredictable storms. This research, like a skilled navigator, explores new pathways to navigate this difficult terrain. The researchers found that tomoxetine, like a reliable compass, can guide individuals through the challenges of ADHD, helping them to better focus and manage their symptoms. This promising discovery offers hope for individuals with ADHD, potentially leading to improved quality of life and greater well-being.

Dr. Camel's Conclusion

The journey through ADHD can be challenging, but research continues to uncover new paths to better health and well-being. This study offers a glimmer of hope for adults with ADHD, suggesting that tomoxetine could be a valuable tool for managing symptoms and improving quality of life. By continuing to explore innovative treatments and support strategies, we can help individuals navigate the challenging landscape of ADHD and strive towards a more fulfilling life.

Date :
  1. Date Completed 1998-05-28
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

9585725

DOI: Digital Object Identifier

10.1176/ajp.155.5.693

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.